The stock of Apellis Pharmaceuticals Inc (NASDAQ: APLS) has decreased by -0.56 when compared to last closing price of 51.79. Despite this, the company has
The stock of Apellis Pharmaceuticals Inc (NASDAQ: APLS) has decreased by -1.95 when compared to last closing price of 56.84.Despite this, the company has seen
The 36-month beta value for APLS is at 0.90. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 1
The stock of Apellis Pharmaceuticals Inc (APLS) has gone down by -5.21% for the week, with a -19.87% drop in the past month and a
© 2024, Fueled by Smart TechOne
